For: | Brzdęk M, Zarębska-Michaluk D, Rzymski P, Lorenc B, Kazek A, Tudrujek-Zdunek M, Janocha-Litwin J, Mazur W, Dybowska D, Berak H, Parfieniuk-Kowerda A, Klapaczyński J, Sitko M, Sobala-Szczygieł B, Piekarska A, Flisiak R. Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era. World J Gastroenterol 2023; 29(13): 2015-2033 [PMID: PMC10122793 DOI: 10.3748/wjg.v29.i13.2015] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i13/2015.htm |
Number | Citing Articles |
1 |
Robert Flisiak, Dorota Zarębska‐Michaluk, Ewa Janczewska, Anna Parfieniuk‐Kowerda, Włodzimierz Mazur, Marek Sitko, Justyna Janocha‐Litwin, Rafał Krygier, Beata Lorenc, Anna Piekarska, Barbara Sobala‐Szczygieł, Krystyna Dobrowolska, Łukasz Socha, Jerzy Jaroszewicz. Sustained Virological Response After Early Discontinuation of Hepatitis C Treatment. Journal of Viral Hepatitis 2024; 31(11): 677 doi: 10.1111/jvh.13991
|
2 |
Nadiia Kasianchuk, Krystyna Dobrowolska, Sofiia Harkava, Andreea Bretcan, Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Robert Flisiak, Piotr Rzymski. Gene-Editing and RNA Interference in Treating Hepatitis B: A Review. Viruses 2023; 15(12): 2395 doi: 10.3390/v15122395
|
3 |
Emma Warren, Belinda J. C. Castles, Gillian C. Sharratt, Aitor Arteaga. Direct-Acting Antivirals Remain Cost-Effective Treatments for Chronic Hepatitis C in Australia Despite Changes to the Treated Population and the Availability of Retreatment: The Glecaprevir/Pibrentasvir (Maviret®) Example. Infectious Diseases and Therapy 2024; 13(3): 549 doi: 10.1007/s40121-024-00926-1
|
4 |
Piotr Rzymski, Michał Brzdęk, Krystyna Dobrowolska, Barbara Poniedziałek, Aleksandra Murawska-Ochab, Dorota Zarębska-Michaluk, Robert Flisiak. Like a Rolling Stone? A Review on Spontaneous Clearance of Hepatitis C Virus Infection. Viruses 2024; 16(9): 1386 doi: 10.3390/v16091386
|
5 |
Dorota Dybowska, Dorota Zarębska-Michaluk, Piotr Rzymski, Hanna Berak, Beata Lorenc, Marek Sitko, Michał Dybowski, Włodzimierz Mazur, Magdalena Tudrujek-Zdunek, Justyna Janocha-Litwin, Ewa Janczewska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Anna Piekarska, Barbara Sobala-Szczygieł, Krystyna Dobrowolska, Malgorzata Pawłowska, Robert Flisiak. Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders. World Journal of Gastroenterology 2023; 29(25): 4085-4098 doi: 10.3748/wjg.v29.i25.4085
Abstract(779) |
Core Tip(709) |
Full Article(HTML)(2572)
|
Full Article with Cover (PDF)-2007K(139)
|
Full Article (Word)-299K(60)
|
Audio-635K(11)
|
Peer-Review Report-210K(101)
|
Answering Reviewers-62K(85)
|
Full Article (PDF)-755K(262)
|
Full Article (XML)-147K(88)
|
Times Cited (4)
|
Total Visits (7703)
|
Open
|
6 |
Agnieszka Genowska, Dorota Zarębska-Michaluk, Krystyna Dobrowolska, Krzysztof Kanecki, Paweł Goryński, Piotr Tyszko, Katarzyna Lewtak, Piotr Rzymski, Robert Flisiak. Trends in Hospitalizations of Patients with Hepatitis C Virus in Poland between 2012 and 2022. Journal of Clinical Medicine 2024; 13(18): 5618 doi: 10.3390/jcm13185618
|
7 |
Ismaeel A Alshoaibi, Abdullah Al-Gamli, Mohammed Abdullah, Basheer Abdo, Khaled H Alzanen, Mohammed Alhakamy, Mamoon Al-Namer, Faisal Ahmed, Munther Tamesh , Wadhah Mahdi , Zeyad Abdo, Marwa Mohammed . Effectiveness of Ledipasvir-Sofosbuvir 12 Weeks After Hepatitis C Virus Genotype 1 Infection and the Factors Associated With Sustained Virologic Response: A Retrospective Study. Cureus 2024; doi: 10.7759/cureus.68249
|
8 |
Karthik Gnanapandithan, Lauren Stemboroski, Abbey Johnston, Maged P. Ghali. Distribution and inflammatory potential of hepatitis C virus genotypes in the United States, 2011–2020. JGH Open 2024; 8(11) doi: 10.1002/jgh3.70049
|